Price cuts put Belgium's medicines supply at risk, warns pharma industry

EURACTIV - Belgium's 2026 health insurance budget foresees €1.5 billion in extra spending and €470 million in savings, nearly half from the pharmaceutical sector. The new savings proposal led to the breakdown of budget talks between the government and Belgium's pharma sector, and has drawn criticism in parliament, along with a sharp response from Medaxes, representing Belgium's generics and biosimilars sector. Read more

[Getty Images: baona]